Exploring patients' reasons for discontinuance of heart medications

L Garavalia, B Garavalia, JA Spertus… - Journal of …, 2009 - journals.lww.com
Background: Despite the importance of secondary prevention, nonadherence rates for
patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence …

[HTML][HTML] Exploring Patients' Reasons for Discontinuance of Heart Medications

L Garavalia, B Garavalia, JA Spertus… - The Journal of …, 2009 - ncbi.nlm.nih.gov
Background Despite the importance of secondary prevention, non-adherence rates for
myocardial infarction (MI) patients range from 13-60% for prescribed, evidence-based …

Exploring patients' reasons for discontinuance of heart medications.

L Garavalia, B Garavalia, JA Spertus… - The Journal of …, 2009 - europepmc.org
Background Despite the importance of secondary prevention, nonadherence rates for
patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence …

Exploring patients' reasons for discontinuance of heart medications

L Garavalia, B Garavalia… - The Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Despite the importance of secondary prevention, nonadherence rates for
patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence …

Exploring Patients' Reasons for Discontinuance of Heart Medications

L Garavalia, B Garavalia, JA Spertus… - Journal of …, 2009 - journals.lww.com
Background: Despite the importance of secondary prevention, nonadherence rates for
patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence …

Exploring patients' reasons for discontinuance of heart medications.

L Garavalia, B Garavalia, JA Spertus… - The Journal of …, 2009 - europepmc.org
Background Despite the importance of secondary prevention, nonadherence rates for
patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence …